Information  X 
Enter a valid email address

FastForward Inn Ltd (FFWD)

  Print   

Friday 26 February, 2021

FastForward Inn Ltd

Investor Presentation

RNS Number : 4282Q
FastForward Innovations Limited
26 February 2021
 

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

26 February 2021

FastForward Innovations Ltd ("FastForward" or, "FFWD")

 

Investor Presentation

 

FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to announce that CEO, Ed McDermott and Finance Director, Lance De Jersey, will provide a live investor presentation via the Investor Meet Company platform on 3rd March 2021 at 11:00am GMT. The investor presentation will provide an overview of each asset in the Company's portfolio as well an update on general market trends.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet FastForward Innovations Limited via:

 

https://www.investormeetcompany.com/fastforward-innovations-limited/register-investor

 

Investors who already follow FastForward Innovations Limited on the Investor Meet Company platform will automatically be invited.

ENDS

 

For further information on the Company please visit www.fstfwd.co   or contact:

Ed McDermott

Lance de Jersey

FastForward Innovations Ltd

E: [email protected]  

 

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Catherine Leftley

Beth Melluish

St Brides Partners Ltd,

Financial PR

E: [email protected]

 

Notes

FastForward Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRATAMMTMTATTFB

a d v e r t i s e m e n t